GE HealthCare Adds Stryker CEO Kevin Lobo to Board
Event summary
- Kevin Lobo, CEO of Stryker Corporation, joins GE HealthCare's Board of Directors effective March 13, 2026.
- Lobo brings over 25 years of experience in medical technology, operations, and finance.
- He previously held leadership roles at Johnson & Johnson, Rhône-Poulenc, KPMG, Unilever, and Kraft Canada.
- GE HealthCare is a $20.6 billion global healthcare solutions provider with approximately 54,000 employees.
The big picture
Kevin Lobo's appointment to GE HealthCare's Board brings deep medtech expertise, aligning with the company's focus on advanced medical technology and global scaling. This move underscores a trend toward operational leadership in healthcare governance, reflecting the industry's emphasis on innovation and precision patient care.
What we're watching
- Strategic Alignment
- How Kevin Lobo's experience at Stryker will influence GE HealthCare's innovation and scaling strategies.
- Industry Trends
- Whether Lobo's appointment signals a broader shift in medtech board compositions toward operational experts.
- Execution Risk
- The pace at which GE HealthCare can integrate Lobo's insights into its growth and innovation priorities.